# Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype

> **NCT06269900** · PHASE3 · RECRUITING · sponsor: **Nantes University Hospital** · enrollment: 450 (estimated)

## Conditions studied

- Hospital Acquired Pneumonia

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06269900
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-26
- **Primary completion:** 2026-03-14
- **Final completion:** 2026-08-15
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06269900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06269900, "Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT06269900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*